🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the effect of formulation on ...
Status
Not Yet Recruiting
Location
Hangzhou First People's Hospital
Start Date
2024-10
Trial ID
NCT06608329
Treatments Being Tested
This is a multicenter, randomized, double-blind, active-controlled, paralle...
Status
Recruiting
Location
Yueyang People's Hospital
Start Date
2025-07-14
Trial ID
NCT07082114
Treatments Being Tested
The aim of this trial is to evaluate the effect of a single oral dose of HD...
Status
Recruiting
Location
PKUcare Luzhong Hospital
Start Date
2026-03-07
Trial ID
NCT07594847
Treatments Being Tested
The purpose of this study is to characterize the effect of rifampicin and i...
Status
Not Yet Recruiting
Location
The second hospital of anhui medical university
Start Date
2024-08-16
Trial ID
NCT06562088
Treatments Being Tested
The purpose of this study is to characterize the drug-drug intereaction of ...
Status
Recruiting
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2025-09-24
Trial ID
NCT07331389
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-08-12
Trial ID
NCT07193459
Treatments Being Tested
In this study, a single dose of \[14C\] radiolabelled HDM1002 will be admin...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-08-27
Trial ID
NCT06576401
Treatments Being Tested
The current study is proposed to evaluate whether there is any clinically m...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-03-18
Trial ID
NCT06985615
Treatments Being Tested
It is a multicenter, randomized, double-blind, placebo-controlled phase II ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06500299
Treatments Being Tested
This is a randomized, double-blind, placebo controlled, parallel group stud...
Status
Completed
Location
The Chinese People's Liberation Army General Hospital
Start Date
2024-06-27
Trial ID
NCT06481085
Treatments Being Tested